A citation-based method for searching scientific literature

Karina Alviña, Kamran Khodakhah. J Neurosci 2010
Times Cited: 115







List of co-cited articles
874 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.
Joy T Walter, Karina Alviña, Mary D Womack, Carolyn Chevez, Kamran Khodakhah. Nat Neurosci 2006
285
39

Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
M Strupp, R Kalla, M Dichgans, T Freilinger, S Glasauer, T Brandt. Neurology 2004
149
33

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
115
31

4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Roger Kalla, Stefan Glasauer, Ulrich Büttner, Thomas Brandt, Michael Strupp. Brain 2007
78
38

KCa channels as therapeutic targets in episodic ataxia type-2.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
77
38

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
M Strupp, O Schüler, S Krafczyk, K Jahn, F Schautzer, U Büttner, T Brandt. Neurology 2003
156
29

Detection of floccular hypometabolism in downbeat nystagmus by fMRI.
R Kalla, A Deutschlander, K Hufner, T Stephan, K Jahn, S Glasauer, T Brandt, M Strupp. Neurology 2006
62
33


Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3.
Vikram G Shakkottai, Maria do Carmo Costa, James M Dell'Orco, Ananthakrishnan Sankaranarayanan, Heike Wulff, Henry L Paulson. J Neurosci 2011
134
19

Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2.
Adebimpe W Kasumu, Charlotte Hougaard, Frederik Rode, Thomas A Jacobsen, Jean Marc Sabatier, Birgitte L Eriksen, Dorte Strøbæk, Xia Liang, Polina Egorova, Dasha Vorontsova,[...]. Chem Biol 2012
86
22

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
R A Ophoff, G M Terwindt, M N Vergouwe, R van Eijk, P J Oefner, S M Hoffman, J E Lamerdin, H W Mohrenweiser, D E Bulman, M Ferrari,[...]. Cell 1996
18

Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.
Stephen T Hansen, Pratap Meera, Thomas S Otis, Stefan M Pulst. Hum Mol Genet 2013
108
18

Increased noise level of purkinje cell activities minimizes impact of their modulation during sensorimotor control.
F E Hoebeek, J S Stahl, A M van Alphen, M Schonewille, C Luo, M Rutteman, A M J M van den Maagdenberg, P C Molenaar, H H L M Goossens, M A Frens,[...]. Neuron 2005
111
18

Downbeat nystagmus: aetiology and comorbidity in 117 patients.
J N Wagner, M Glaser, T Brandt, M Strupp. J Neurol Neurosurg Psychiatry 2008
97
17

4-aminopyridine and cerebellar gait: a retrospective case series.
Roman Schniepp, Max Wuehr, Maximilian Neuhaeusser, Ann Kathrin Benecke, Christine Adrion, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2012
42
40

Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Raphael Hourez, Laurent Servais, David Orduz, David Gall, Isabelle Millard, Alban de Kerchove d'Exaerde, Guy Cheron, Harry T Orr, Massimo Pandolfo, Serge N Schiffmann. J Neurosci 2011
88
19

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
Jing Liu, Tie-Shan Tang, Huiping Tu, Omar Nelson, Emily Herndon, Duong P Huynh, Stefan M Pulst, Ilya Bezprozvanny. J Neurosci 2009
189
16

4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
S Glasauer, R Kalla, U Büttner, M Strupp, T Brandt. J Neurol Neurosurg Psychiatry 2005
57
26

Primary episodic ataxias: diagnosis, pathogenesis and treatment.
J C Jen, T D Graves, E J Hess, M G Hanna, R C Griggs, R W Baloh. Brain 2007
203
14

Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Roger Kalla, Rainer Spiegel, Jens Claassen, Stanislavs Bardins, Ales Hahn, Erich Schneider, Nicole Rettinger, Stefan Glasauer, Thomas Brandt, Michael Strupp. J Neuroophthalmol 2011
30
46

Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering.
Catherine J C Weisz, Robert S Raike, Luis E Soria-Jasso, Ellen J Hess. J Neurosci 2005
48
27

A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Jens Claassen, Rainer Spiegel, Roger Kalla, Mary Faldon, Christopher Kennard, Chotipat Danchaivijitr, Stanislaw Bardins, Nicole Rettinger, Erich Schneider, Thomas Brandt,[...]. J Neurol Neurosurg Psychiatry 2013
52
25

Effects of ablation of flocculus and paraflocculus of eye movements in primate.
D S Zee, A Yamazaki, P H Butler, G Gücer. J Neurophysiol 1981
658
12

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
R Kalla, S Glasauer, F Schautzer, N Lehnen, U Büttner, M Strupp, T Brandt. Neurology 2004
55
21

Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Michael Strupp, Roger Kalla, Stefan Glasauer, Judith Wagner, Katharina Hüfner, Klaus Jahn, Thomas Brandt. Prog Brain Res 2008
38
31


Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice.
Zhenyu Gao, Boyan Todorov, Curtis F Barrett, Stijn van Dorp, Michel D Ferrari, Arn M J M van den Maagdenberg, Chris I De Zeeuw, Freek E Hoebeek. J Neurosci 2012
64
18

Clinical spectrum of episodic ataxia type 2.
J Jen, G W Kim, R W Baloh. Neurology 2004
183
11

Episodic ataxia type 2.
Michael Strupp, Andreas Zwergal, Thomas Brandt. Neurotherapeutics 2007
98
11


Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
95
11

Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity.
Melanie D Mark, Martin Krause, Henk-Jan Boele, Wolfgang Kruse, Stefan Pollok, Thomas Kuner, Deniz Dalkara, Sebastiaan Koekkoek, Chris I De Zeeuw, Stefan Herlitze. J Neurosci 2015
40
27

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
108
11

Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
James M Dell'Orco, Aaron H Wasserman, Ravi Chopra, Melissa A C Ingram, Yuan-Shih Hu, Vikrant Singh, Heike Wulff, Puneet Opal, Harry T Orr, Vikram G Shakkottai. J Neurosci 2015
62
17

In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
Polina A Egorova, Olga A Zakharova, Olga L Vlasova, Ilya B Bezprozvanny. J Neurophysiol 2016
41
26

18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
Sandra Bense, Christoph Best, Hans-Georg Buchholz, Valerie Wiener, Mathias Schreckenberger, Peter Bartenstein, Marianne Dieterich. Neuroreport 2006
36
27

The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Taiji Tsunemi, Kinya Ishikawa, Kei Tsukui, Takuro Sumi, Ken Kitamura, Hidehiro Mizusawa. J Neurol Sci 2010
21
47

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
106
10

4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.
Roman Schniepp, Max Wuehr, Nibal Ackl, Adrian Danek, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2011
24
41

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.
Xi Chen, Tie-Shan Tang, Huiping Tu, Omar Nelson, Mark Pook, Robert Hammer, Nobuyuki Nukina, Ilya Bezprozvanny. J Neurosci 2008
161
10




Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.
Michael Strupp, Matthew J Thurtell, Aasef G Shaikh, Thomas Brandt, David S Zee, R John Leigh. J Neurol 2011
65
15

Spatiotemporal firing patterns in the cerebellum.
Chris I De Zeeuw, Freek E Hoebeek, Laurens W J Bosman, Martijn Schonewille, Laurens Witter, Sebastiaan K Koekkoek. Nat Rev Neurosci 2011
247
10

Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Jens Claassen, Julian Teufel, Roger Kalla, Rainer Spiegel, Michael Strupp. J Neurol 2013
21
47

Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series.
Michael Strupp, Julian Teufel, Maximilian Habs, Regina Feuerecker, Carolin Muth, Bart P van de Warrenburg, Thomas Klopstock, Katharina Feil. J Neurol 2013
51
19

4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6.
Sriram Jayabal, Hui Ho Vanessa Chang, Kathleen E Cullen, Alanna J Watt. Sci Rep 2016
43
23

Hereditary paroxysmal ataxia: response to acetazolamide.
R C Griggs, R T Moxley, R A Lafrance, J McQuillen. Neurology 1978
160
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.